z-logo
Premium
The effect of trimoprostil (trimethyldesoxy prostaglandin E 2 ) on the intrauterine pressure in women
Author(s) -
Reele Stots B,
NaussKarol Cheryl,
Lusaitis Audrey A,
Passe Sharon M
Publication year - 1988
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1988.134
Subject(s) - uterotonic , medicine , placebo , prostaglandin analogue , prostaglandin e2 , crossover study , prostaglandin , anesthesia , adverse effect , oxytocin , alternative medicine , pathology
Prostaglandin E 2 is uterotonic. Trimoprostil, a prostaglandin E 2 analog, is a gastric antisecretory and cytoprotective agent. The effects of single doses of 0, 0.125, 0.75, and 3.0 mg trimoprostil on intrauterine pressure were measured in a double‐blind, crossover study in eight surgically sterile women. The 3 mg dose was not tolerated because of abdominal cramps. The other doses caused a dose‐related increase in resting uterine tone and peak pressure with peak effect occurring between 30 and 60 minutes after administration with a duration of about 120 minutes. No effects on the frequency of uterine contractions occurred. Peak mean tone increased from 11.0 to 71.2 mm Hg ( p < 0.01) and peak pressure from 24.6 to 125.1 mm Hg ( p < 0.01) after placebo compared with the 1.5 mg dose. Adverse reactions included abdominal pain that correlated with an increase in intrauterine pressure and tone. Clinical Pharmacology and Therapeutics (1988) 44 , 179–185; doi: 10.1038/clpt.1988.134

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom